Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Le Gallo

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 13, 2017
CD95 Stimulation with CD95L and DISC AnalysisMatthieu Le Gallo, Patrick Legembre
Clinical Chemistry|October 31, 2013
The emerging genomic landscape of endometrial cancerMatthieu Le Gallo, Daphne W Bell
Cell Death & Disease|March 18, 2022
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseasesVesna Risso, Elodie Lafont, Matthieu Le Gallo
The FEBS Journal|June 16, 2026
Ubiquitin and ubiquitin-like modifications in the endoplasmic reticulum stress responseTony Avril, Matthieu Le Gallo, Elodie Lafont
Current Opinion in Genetics & Development|January 27, 2015
The mutational landscape of endometrial cancerBo Hong, Matthieu Le Gallo, Daphne W Bell
Advances in Experimental Medicine and Biology|December 3, 2016
Next-Generation SequencingMatthieu Le Gallo, Fred Lozy, Daphne W Bell
Frontiers in Immunology|October 13, 2017
CD95/Fas, Non-Apoptotic Signaling Pathways, and KinasesMatthieu Le Gallo, Amanda Poissonnier, Patrick Blanco, et al.
Cancer Genetics|November 4, 2019
High-resolution copy number analysis of clear cell endometrial carcinomaAndrea J O'Hara, Matthieu Le Gallo, Meghan L Rudd, et al.
Trends in Biochemical Sciences|November 9, 2023
UFMylation: a ubiquitin-like modificationXingchen Zhou, Sayyed J Mahdizadeh, Matthieu Le Gallo, et al.
STAR Protocols|March 15, 2022
A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19Sophie Martin, Gwénaële Jégou, Aurore Nicolas, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|January 13, 2017
CD95 Stimulation with CD95L and DISC AnalysisMatthieu Le Gallo, Patrick Legembre
Clinical Chemistry|October 31, 2013
The emerging genomic landscape of endometrial cancerMatthieu Le Gallo, Daphne W Bell
Cell Death & Disease|March 18, 2022
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseasesVesna Risso, Elodie Lafont, Matthieu Le Gallo
The FEBS Journal|June 16, 2026
Ubiquitin and ubiquitin-like modifications in the endoplasmic reticulum stress responseTony Avril, Matthieu Le Gallo, Elodie Lafont
Current Opinion in Genetics & Development|January 27, 2015
The mutational landscape of endometrial cancerBo Hong, Matthieu Le Gallo, Daphne W Bell
Advances in Experimental Medicine and Biology|December 3, 2016
Next-Generation SequencingMatthieu Le Gallo, Fred Lozy, Daphne W Bell
Frontiers in Immunology|October 13, 2017
CD95/Fas, Non-Apoptotic Signaling Pathways, and KinasesMatthieu Le Gallo, Amanda Poissonnier, Patrick Blanco, et al.
Cancer Genetics|November 4, 2019
High-resolution copy number analysis of clear cell endometrial carcinomaAndrea J O'Hara, Matthieu Le Gallo, Meghan L Rudd, et al.
Trends in Biochemical Sciences|November 9, 2023
UFMylation: a ubiquitin-like modificationXingchen Zhou, Sayyed J Mahdizadeh, Matthieu Le Gallo, et al.
STAR Protocols|March 15, 2022
A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19Sophie Martin, Gwénaële Jégou, Aurore Nicolas, et al.
Pageof 4